Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Current active episode of BV (diagnosis defined as: At least 3 of the 4 Amsel criteria; Nugent score of at least 4; presence of BV-related symptoms)~* History of recurrent BV (at least 3 episodes in previous year including current episode)~* Using an effective method of contraception~Exclusion Criteria:~* Test positive for a sexually transmitted infection~* Presence of genital Herpes Simplex Virus (HSV) lesions or Human Papilloma Virus (HPV) lesions requiring treatment~* Abnormal pelvic exam, including presence of other vaginal or urinary tract infections~* Pregnancy

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- 1% SPL7013 Gel (Type: EXPERIMENTAL): Inserted in to the vagina on alternate days (i.e. every other day) for 16 weeks
- Placebo Gel (Type: PLACEBO_COMPARATOR): Inserted in to the vagina on alternate days (i.e. every other day) for 16 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).